Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details Narrative)

v3.10.0.1
Significant Accounting Policies (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 22, 2017
Sep. 30, 2018
USD ($)
Breathalyzers
shares
Sep. 30, 2017
USD ($)
Breathalyzers
shares
Sep. 30, 2018
USD ($)
Breathalyzers
shares
Sep. 30, 2017
USD ($)
Breathalyzers
shares
Dec. 31, 2017
USD ($)
Restricted cash   $ 500,000   $ 500,000  
Maturities of securities       less than one year    
Unrealized loss on securities   6,900 $ 5,543  
Unrealized gain on securities     1,900   0  
Proceeds from the sale of marketable securities   3,153,987 1,003,565 5,460,662 2,749,119  
Marketable securities, loss   6,900   11,300    
Marketable securities, gain     1,719   3,375  
Allowances for doubtful accounts for trade receivables   693,196   693,196   596,196
Bad debt expenses   0 0 125,500 47,741  
Trade receivables   283,228   283,228   964,671
Trade payables   2,254,199   2,254,199   1,745,216
Depreciation   17,366 18,709 44,716 54,536  
Intangible assets, net   1,002,336   1,002,336   1,130,667
Intangible assets, accumulated amortization   3,897,635   3,897,635    
Impairment of intangible assets     2,895,299  
Amortization expense   42,777 42,777 128,331 128,331  
Accrued liabilities   71,632   71,632   126,471
Deferred revenue, recognized   26,262 51,791 70,156 224,469  
Unrecognized tax benefits      
Income Tax Examination, Description 0.35     The Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017. The Tax Act reduced the U.S. federal corporate tax rate from 35% to 21%.    
Income tax rate, percentage       21.00%    
Cost of net revenue   18,126 16,148 $ 83,063 63,719  
Net loss attributable to common shareholders   $ 3,083,949 $ 1,177,644 $ 7,011,394 $ 3,344,932  
Weighted average basic and diluted common shares outstanding | shares   11,779,584 1,111,510 10,805,151 1,033,606  
Shipping and Handling [Member]            
Income tax rate, percentage   862500.00% 1367900.00% 4100600.00% 4714800.00%  
Supplier One [Member]            
Concentration risk percentage   25.00%        
Supplier Two [Member]            
Concentration risk percentage   18.00%        
Supplier Three [Member]            
Concentration risk percentage   11.00%        
Three Suppliers [Member]            
Concentration risk percentage   54.00%        
One Suppliers [Member]            
Concentration risk percentage       14.00%    
Suppliers One [Member]            
Concentration risk percentage     18.00%      
Suppliers Two [Member]            
Concentration risk percentage     13.00%      
Two Suppliers [Member]            
Concentration risk percentage     31.00%      
One Supplier [Member]            
Concentration risk percentage         11.00%  
Sales Revenue, Net [Member]            
Concentration risk percentage   95.00% 69.00% 72.00% 72.00%  
Concentration risk, number of customer | Breathalyzers   3 2 2 3  
Sales Revenue, Net [Member] | Customer One [Member]            
Concentration risk percentage   61.00% 42.00% 55.00% 34.00%  
Sales Revenue, Net [Member] | Customer Two [Member]            
Concentration risk percentage   18.00% 27.00% 17.00% 21.00%  
Sales Revenue, Net [Member] | Customer Three [Member]            
Concentration risk percentage   16.00%     17.00%  
Sales Revenue, Net [Member] | Two Customers [Member]            
Due from customers   $ 69,567   $ 69,567    
Trade Receivable [Member]            
Concentration risk, number of customer | Breathalyzers       3    
Trade Receivable [Member] | Customer One [Member]            
Concentration risk percentage       47.00%    
Trade receivables   457,881   $ 457,881    
Trade Receivable [Member] | Customer Two [Member]            
Concentration risk percentage       15.00%    
Trade receivables   146,196   $ 146,196    
Trade Receivable [Member] | Customer Three [Member]            
Concentration risk percentage       13.00%    
Trade receivables   127,329   $ 127,329    
Trade Payables [Member]            
Concentration risk percentage       35.00%    
Trade Payables [Member] | Vendor One [Member]            
Concentration risk percentage       21.00%    
Trade payables   150,668   $ 150,668    
Trade Payables [Member] | Vendor Two [Member]            
Concentration risk percentage       14.00%    
Trade payables   $ 98,738   $ 98,738    
Maximum [Member]            
Normal credit terms extended to customers       90 days    
Minimum [Member]            
Normal credit terms extended to customers       30 days    
November 8 2018 [Member]            
Reverse stock split       On November 8, 2018, the Company effectuated a reverse stock split of its shares of common stock whereby every eight (8) pre-split shares of common stock were exchanged for one (1) post-split share of the Company's common stock (“Reverse Stock Split”).